REG - Nanoco Group PLC - Director/PDMR Shareholding

NanocoAnnouncement

02/05/2019 18:10

RNS Number : 9561X
Nanoco Group PLC
02 May 2019
 


NANOCO GROUP PLC
("Nanoco", the "Group", or the "Company") 
Director/PDMR Shareholding
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, has been notified that Dr Michael Edelman, Chief Executive Officer, and Dr Nigel Pickett, Chief Technology Director, sold ordinary shares of 10p each in the Company as set out below.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
 Notification of Dealing Form



1.


Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")




a)


Name


MICHAEL EDELMAN




2.


Reason for the notification: SALE OF ORDINARY SHARES




a)


Position /status


CHIEF EXECUTIVE OFFICER




b)


Initial notification / amendment


INITIAL NOTIFICATION




3.


Details of the Issuer




a)


Name


NANOCO GROUP PLC




b)


LEI code


213800HOSJEZO1KOCV33




4.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Type of instrument:

Identification code


ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES")




ISIN: GB00B01JLR99




b)


Nature of the transaction


SALE OF ORDINARY SHARES




c)


Price(s) and volume(s)





Price(s)


Volume(s)




50.02p
48p
45p


242,857
60,680
1,696,463








d)


Aggregated information:

- Aggregated volume

- Price





Price(s)


Volume(s)




45.7p


2,000,000








e)


Date of the transaction


30 APRIL 2019 TO 02 MAY 2019




f)


Place of the transaction


LONDON STOCK EXCHANGE



 



1.


Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")




a)


Name


NIGEL PICKETT




2.


Reason for the notification: SALE OF ORDINARY SHARES




a)


Position /status


CHIEF TECHNOLOGY OFFICER




b)


Initial notification / amendment


INITIAL NOTIFICATION




3.


Details of the Issuer




a)


Name


NANOCO GROUP PLC




b)


LEI code


213800HOSJEZO1KOCV33




4.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Type of instrument:

Identification code


ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES")




ISIN: GB00B01JLR99




b)


Nature of the transaction


SALE OF ORDINARY SHARES




c)


Price(s) and volume(s)





Price(s)


Volume(s)




50.02p
48p


182,143
45,510








d)


Aggregated information:

- Aggregated volume

- Price





Price(s)


Volume(s)




49.6161p


227,653








e)


Date of the transaction


30 APRIL 2019 TO 02 MAY 2019




f)


Place of the transaction


LONDON STOCK EXCHANGE



 
This announcement contains inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014.
For further information, please contact:
Nanoco Group PLC:
Michael Edelman, CEO                                                                                                       +44 (0) 161 603 7900
Brian Tenner, COO & CFO                                                                                                  +44 (0) 161 603 7900
Caroline Watson, Investor Relations Manager                                                                     +44 (0) 7799 897 357
cwatson@nanocotechnologies.com
 
MHP Communications:                                                                                                      +44 (0) 203 128 8570
Reg Hoare
Giles Robinson
Pete Lambie
nanoco@mhpc.com




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKBDKOBKDOPK